| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 336,577 | 340,045 | 332,010 | 350,995 | | Cost of Revenue | 107,298 | 96,034 | 123,609 | 120,020 | | | Gross Profit | 229,279 | 244,011 | 208,401 | 230,975 | | | Operating Expenses | | Research Development | 14,751 | 16,422 | 18,088 | 65,457 | | Selling General and Administrative | 176,869 | 198,559 | 195,847 | 128,816 | | Non Recurring |
-
|
-
| 1,056 | 11,600 | | Others | 30,538 | 25,123 | 26,534 | 46,883 | | | | Total Operating Expenses |
-
|
-
| 241,525 | 252,756 | | | | Operating Income or Loss | 7,121 | 3,907 | (33,124) | (21,781) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 56,266 | 64,255 | 3,874 | 308,424 | | Earnings Before Interest And Taxes | 59,426 | 65,997 | (31,097) | 287,910 | | Interest Expense | 1,345 | 1,261 | 1,464 | 1,498 | | Income Before Tax | 58,081 | 64,736 | (32,561) | 286,412 | | Income Tax Expense | 34,269 | 22,143 | (2,679) | 65,876 | | Minority Interest | (674) | 674 |
-
| 4,654 | | | | Net Income From Continuing Ops | 23,138 | 43,267 | (29,882) | 225,190 | | | Non-recurring Events | | Discontinued Operations | (2,514) | (2,196) | 1,238 | 2,227 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,624 | 41,071 | (28,644) | 227,417 | | Preferred Stock And Other Adjustments | 1,058 | (258) | 258 |
-
| | | Net Income Applicable To Common Shares | $21,682 | $40,813 | ($28,386) | $227,417 |
|
0.01% Nasdaq 
0.22%
Income Statement
